D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Duopharma Biotech Bhd
Pre-Tax Income Peer Comparison

Comparables:
P
PLABS
A
AHEALTH
R
RHONEMA
Y
YSPSAH
K
KOTRA

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Pre-Tax Income
myr60.5m
CAGR 3-Years
-10%
CAGR 5-Years
-3%
CAGR 10-Years
4%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Pre-Tax Income
myr5.3m
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
6%
A
Apex Healthcare Bhd
KLSE:AHEALTH
Pre-Tax Income
myr114.5m
CAGR 3-Years
19%
CAGR 5-Years
12%
CAGR 10-Years
11%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Pre-Tax Income
myr21.3m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Pre-Tax Income
myr48.5m
CAGR 3-Years
40%
CAGR 5-Years
7%
CAGR 10-Years
9%
K
Kotra Industries Bhd
KLSE:KOTRA
Pre-Tax Income
myr56.5m
CAGR 3-Years
29%
CAGR 5-Years
21%
CAGR 10-Years
26%

See Also

What is Duopharma Biotech Bhd's Pre-Tax Income?
Pre-Tax Income
60.5m MYR

Based on the financial report for Jun 30, 2024, Duopharma Biotech Bhd's Pre-Tax Income amounts to 60.5m MYR.

What is Duopharma Biotech Bhd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
4%

Over the last year, the Pre-Tax Income growth was -26%. The average annual Pre-Tax Income growth rates for Duopharma Biotech Bhd have been -10% over the past three years , -3% over the past five years , and 4% over the past ten years .

Back to Top